Moreover, biologic therapy has been shown to have a hepatoprotective role even in psoriasis patients with pre-existing liver injury, especially the newer therapeutic classes (IL-17 inhibitors and IL-12/23 inhibitors). This evidence concerns the gene IL17A and psoriasis.